Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors1
Patient-derived xenograft (PDX) tumor models have emerged as a new approach to evaluate the effects of cancer drugs on patients’ personalized tumor grafts enabling to select the best treatment for the cancer patient and providing a new tool for oncology drug developers. Here, we report that human tu...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Neoplasia Press
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611072/ |